This company has been acquired
Silk Road Medical Past Earnings Performance
Past criteria checks 0/6
Silk Road Medical's earnings have been declining at an average annual rate of -3.1%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 26.1% per year.
Key information
-3.1%
Earnings growth rate
23.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 26.1% |
| Return on equity | -36.6% |
| Net Margin | -29.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 03
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
May 02Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19Revenue & Expenses Breakdown
How Silk Road Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 191 | -57 | 160 | 43 |
| 31 Mar 24 | 185 | -53 | 152 | 42 |
| 31 Dec 23 | 177 | -56 | 145 | 41 |
| 30 Sep 23 | 170 | -55 | 138 | 40 |
| 30 Jun 23 | 163 | -53 | 131 | 39 |
| 31 Mar 23 | 151 | -55 | 123 | 39 |
| 31 Dec 22 | 139 | -55 | 116 | 36 |
| 30 Sep 22 | 127 | -57 | 111 | 35 |
| 30 Jun 22 | 114 | -61 | 108 | 33 |
| 31 Mar 22 | 107 | -56 | 102 | 30 |
| 31 Dec 21 | 101 | -50 | 96 | 27 |
| 30 Sep 21 | 94 | -52 | 90 | 30 |
| 30 Jun 21 | 90 | -48 | 84 | 27 |
| 31 Mar 21 | 78 | -48 | 77 | 24 |
| 31 Dec 20 | 75 | -47 | 76 | 21 |
| 30 Sep 20 | 73 | -39 | 73 | 14 |
| 30 Jun 20 | 70 | -37 | 71 | 13 |
| 31 Mar 20 | 70 | -38 | 69 | 13 |
| 31 Dec 19 | 63 | -52 | 63 | 12 |
| 30 Sep 19 | 56 | -60 | 57 | 12 |
| 30 Jun 19 | 49 | -61 | 49 | 12 |
| 31 Mar 19 | 42 | -56 | 42 | 11 |
| 31 Dec 18 | 35 | -38 | 35 | 10 |
| 31 Dec 17 | 14 | -19 | 20 | 7 |
Quality Earnings: SILK is currently unprofitable.
Growing Profit Margin: SILK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SILK is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.
Accelerating Growth: Unable to compare SILK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SILK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: SILK has a negative Return on Equity (-36.55%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/16 21:15 |
| End of Day Share Price | 2024/09/16 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Silk Road Medical, Inc is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Joanne Wuensch | BMO Capital Markets Equity Research |
| Travis Steed | BofA Global Research |